发明名称 MODIFIED ADENOVIRAL VECTORS FOR USE IN GENE THERAPY
摘要 The present invention provides means and methods for the generation and manufacturing of recombinant Ad vectors that are modified in E2B and/or E4 functions, preferably, said vectors comprise E1 and/or E2A deletions. For th is purpose, the vector genome is modified in the respective promoter regions su ch that the promoter is only active in a suitable complementing cell line or on ly active following a certain signal in the case of an inducible promoter. The modified promoter is, on the other hand, inactive under normal conditions, a nd in normal mammalian and/or human cells. Hence, vectors that possess said modified promoter in the E2B and/or E4 region do not express the respective transcription region in mammalians and/or humans.
申请公布号 CA2384439(A1) 申请公布日期 2001.03.22
申请号 CA20002384439 申请日期 2000.09.11
申请人 CRUCELL HOLLAND B.V. 发明人 OPSTELTEN, DIRK JAN ELBERTUS;SCHOUTEN, GOVERT JOHAN;VOGELS, RONALD
分类号 C12N7/01;C12N15/861;(IPC1-7):C12N15/86;A61K48/00;C12N5/10 主分类号 C12N7/01
代理机构 代理人
主权项
地址